GlassScriptPhysician profile
Mary E Cohen Colson
NPI 1831145127
$9,717.16
in general payments reported to CMS, 2019-2025
15 companies · $2,239 in 2025
The $2,239 reported for 2025 was more than what 90% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $742 · 2020: $408 · 2021: $841 · 2022: $1,900 · 2023: $1,950 · 2024: $1,639 · 2025: $2,239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,648 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,647.81 |
| Education | $180.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $1,998.16 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Alkermes, INC. | $1,648.22 | 2019-2025 | Aristada, Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,602.30 | 2020-2025 | Caplyta |
| Neurocrine Biosciences, INC. | $1,124.49 | 2019-2025 | Ingrezza |
| Abbvie INC. | $773.81 | 2021-2024 | Vraylar |
| Janssen Pharmaceuticals, INC | $698.09 | 2019-2024 | Invega Sustenna, Invega, Spravato |
| Otsuka America Pharmaceutical, INC. | $674.32 | 2019-2025 | Abilify Maintena, Rexulti |
| Vanda Pharmaceuticals INC. | $487.65 | 2019-2025 | Fanapt, Hetlioz |
| E.R. Squibb & Sons, L.L.C. | $295.22 | 2024-2025 | Cobenfy |
| Lundbeck LLC | $217.08 | 2023-2025 | Rexulti, Abilify Asimtufii |
| Indivior INC. | $83.95 | 2022-2023 | Perseris |
| Allergan, INC. | $49.09 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.33 | 2020 | |
| Axsome Therapeutics, INC. | $23.23 | 2025 | Sunosi |
| Lilly USA, LLC | $17.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Cohen Colson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.